207 related articles for article (PubMed ID: 20303954)
21. Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin.
Houpt E; Barroso L; Lockhart L; Wright R; Cramer C; Lyerly D; Petri WA
Vaccine; 2004 Jan; 22(5-6):611-7. PubMed ID: 14741152
[TBL] [Abstract][Full Text] [Related]
22. Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice.
Ryan ET; Butterton JR; Zhang T; Baker MA; Stanley SL; Calderwood SB
Infect Immun; 1997 Aug; 65(8):3118-25. PubMed ID: 9234763
[TBL] [Abstract][Full Text] [Related]
23. Obtaining of three recombinant antigens of Entamoeba histolytica and evaluation of their immunogenic ability without adjuvant in a hamster model of immunoprotection.
González-Vázquez MC; Carabarin-Lima A; Baylón-Pacheco L; Talamás-Rohana P; Rosales-Encina JL
Acta Trop; 2012 May; 122(2):169-76. PubMed ID: 22266120
[TBL] [Abstract][Full Text] [Related]
24. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].
Yu F; Fan MW; Xu QA; Jia R; Guo JH; Bian Z; Chen Z; Peng B; Fan B
Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):754-9. PubMed ID: 15200917
[TBL] [Abstract][Full Text] [Related]
25. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.
Singh SR; Hulett K; Pillai SR; Dennis VA; Oh MK; Scissum-Gunn K
Vaccine; 2006 Feb; 24(8):1213-24. PubMed ID: 16194585
[TBL] [Abstract][Full Text] [Related]
26. Oral immunization with a recombinant cysteine-rich section of the Entamoeba histolytica galactose-inhibitable lectin elicits an intestinal secretory immunoglobulin A response that has in vitro adherence inhibition activity.
Beving DE; Soong CJ; Ravdin JI
Infect Immun; 1996 Apr; 64(4):1473-6. PubMed ID: 8606122
[TBL] [Abstract][Full Text] [Related]
27. Oral lactoferrin treatment resolves amoebic intracecal infection in C3H/HeJ mice.
León-Sicairos N; Martínez-Pardo L; Sánchez-Hernández B; de la Garza M; Carrero JC
Biochem Cell Biol; 2012 Jun; 90(3):435-41. PubMed ID: 22452668
[TBL] [Abstract][Full Text] [Related]
28. Recognition of Entamoeba histolytica 115-kDa surface protein by human secretory immunoglobulin A antibodies from asymptomatic carriers.
Barbosa-Sabanero G; Avila EE
J Parasitol; 2004 Apr; 90(2):373-8. PubMed ID: 15165062
[TBL] [Abstract][Full Text] [Related]
29. Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.
Corthésy B; Boris S; Isler P; Grangette C; Mercenier A
J Infect Dis; 2005 Oct; 192(8):1441-9. PubMed ID: 16170763
[TBL] [Abstract][Full Text] [Related]
30. Production of antibodies in murine mucosal immunization with Toxoplasma gondii excreted/secreted antigens.
Hafid J; Vincent N; Flori P; Bellete B; Raberin H; Sung RT
Vet Parasitol; 2005 Mar; 128(1-2):23-8. PubMed ID: 15725529
[TBL] [Abstract][Full Text] [Related]
31. An Entamoeba histolytica antigen devoid of enzymatic activity, but endowed with immunogenic and protective properties.
Portnoy L; Oliva A; Antonio-Ramírez J; Castellanos C; del Muro R; Ortíz-Ortíz L
Arch Invest Med (Mex); 1990; 21 Suppl 1():27-34. PubMed ID: 2136496
[TBL] [Abstract][Full Text] [Related]
32. Experimental amebiasis: molecular weight analysis of Entamoeba histolytica antigens recognized by IgG antibodies.
Ghosh PK; Gupta S; Ghosh R; Ruiz BH; Ortiz-Ortiz L
Indian J Exp Biol; 1999 Aug; 37(8):803-6. PubMed ID: 10709329
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Entamoeba histolytica proteolytic activity by human salivary IgA antibodies.
Guerrero-Manríquez GG; Sánchez-Ibarra F; Avila EE
APMIS; 1998 Nov; 106(11):1088-94. PubMed ID: 9890272
[TBL] [Abstract][Full Text] [Related]
34. Strong mucosal adjuvanticity of cholera toxin within lipid particles of a new multiple emulsion delivery system for oral immunization.
Tomasi M; Dertzbaugh MT; Hearn T; Hunter RL; Elson CO
Eur J Immunol; 1997 Oct; 27(10):2720-5. PubMed ID: 9368632
[TBL] [Abstract][Full Text] [Related]
35. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
[TBL] [Abstract][Full Text] [Related]
36. Entamoeba histolytica: cloning, expression and evaluation of the efficacy of a recombinant amebiasis cysteine proteinase gene (ACP1) antigen in minipig.
He GZ
Exp Parasitol; 2012 Feb; 130(2):126-9. PubMed ID: 22154977
[TBL] [Abstract][Full Text] [Related]
37. Antibodies to the serine rich Entamoeba histolytica protein (SREHP) prevent amoebic liver abscess in severe combined immunodeficient (SCID) mice.
Zhang T; Cieslak PR; Foster L; Kunz-Jenkins C; Stanley SL
Parasite Immunol; 1994 May; 16(5):225-30. PubMed ID: 8072766
[TBL] [Abstract][Full Text] [Related]
38. Antigenicity, immunogenicity and vaccine efficacy of the galactose-specific adherence protein of Entamoeba histolytica.
Ravdin JI; Shain DC; Kelsall BL
Vaccine; 1993; 11(2):241-6. PubMed ID: 8438621
[TBL] [Abstract][Full Text] [Related]
39. Progress towards development of a vaccine for amebiasis.
Stanley SL
Clin Microbiol Rev; 1997 Oct; 10(4):637-49. PubMed ID: 9336666
[TBL] [Abstract][Full Text] [Related]
40. Immunoprotective behaviour of plasma-membrane-associated antigens of axenic Entamoeba histolytica.
Vinayak VK; Purnima ; Saxena A
J Med Microbiol; 1987 Dec; 24(4):297-302. PubMed ID: 2891855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
